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Background: An estimated 30 million neonates require inpatient care annually, many with life-threatening
infections. Appropriate antibiotic management is crucial, yet there is no routine measurement of coverage. The
Every Newborn Birth Indicators Research Tracking in Hospitals (EN-BIRTH) study aimed to validate maternal and
newborn indicators to inform measurement of coverage and quality of care. This paper reports validation of
reported antibiotic coverage by exit survey of mothers for hospitalized newborns with clinically-defined infections,
including sepsis, meningitis, and pneumonia.
Methods: EN-BIRTH study was conducted in five hospitals in Bangladesh, Nepal, and Tanzania (July 2017–July
2018). Neonates were included based on case definitions to focus on term/near-term, clinically-defined infection
syndromes (sepsis, meningitis, and pneumonia), excluding major congenital abnormalities. Clinical management
was abstracted from hospital inpatient case notes (verification) which was considered as the gold standard against
which to validate accuracy of women’s report. Exit surveys were conducted using questions similar to The
Demographic and Health Surveys (DHS) approach for coverage of childhood pneumonia treatment. We compared
survey-report to case note verified, pooled across the five sites using random effects meta-analysis.
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Results: A total of 1015 inpatient neonates admitted in the five hospitals met inclusion criteria with clinically-
defined infection syndromes. According to case note verification, 96.7% received an injectable antibiotic, although
only 14.5% of them received the recommended course of at least 7 days. Among women surveyed (n = 910), 98.8%
(95% CI: 97.8–99.5%) correctly reported their baby was admitted to a neonatal ward. Only 47.1% (30.1–64.5%)
reported their baby’s diagnosis in terms of sepsis, meningitis, or pneumonia. Around three-quarters of women
reported their baby received an injection whilst in hospital, but 12.3% reported the correct antibiotic name. Only
10.6% of the babies had a blood culture and less than 1% had a lumbar puncture.
Conclusions: Women’s report during exit survey consistently underestimated the denominator (reporting the baby
had an infection), and even more so the numerator (reporting known injectable antibiotics). Admission to the
neonatal ward was accurately reported and may have potential as a contact point indicator for use in household
surveys, similar to institutional births. Strengthening capacity and use of laboratory diagnostics including blood
culture are essential to promote appropriate use of antibiotics. To track quality of neonatal infection management,
we recommend using inpatient records to measure specifics, requiring more research on standardised inpatient
records.
Keywords: Newborn, Neonatal infections, Sepsis, Antibiotics, Coverage, Quality of care, Hospital records, Survey,
Validity, Antimicrobial resistanceKey findings
What is known and what is new about this study?
• Neonatal infections, including sepsis, pneumonia and meningitis
account for over half a million neonatal deaths annually, yet most of
these deaths are avoidable with appropriate antibiotic and
supportive care management. Currently, there are no data from
surveys or routine health information systems to track coverage of
antibiotic treatment for newborn infections. Such data are
increasingly important given rising antimicrobial resistance (AMR).
• The Every Newborn-Birth Indicators Research Tracking in Hospitals
(EN-BIRTH) study aimed to validate selected maternal and newborn
indicators, including use of injectable antibiotics for treating
inpatient newborns with clinically-defined infections. This is the first
study to assess validity of this indicator in exit survey of women’s re-
port, compared to inpatient case notes, and involved more than
1000 neonates in five hospitals in Bangladesh, Nepal and Tanzania.
Survey – what did we find and what does it mean?
• Denominator: Maternal report of admission of a newborn to the
inpatient ward had high sensitivity, but diagnoses of infection or
specific infection syndromes were poorly reported, with high rates
of “Don’t know” replies.
• Numerator: Women’s report consistently underestimated the
coverage of injectable antibiotics for treating newborns compared
to the coverage defined by inpatient case note records, and specific
antibiotic names were rarely reported correctly.
Gap analysis for quality of care and measurement
• Inpatient case note records could be used to measure antibiotic
coverage, but limited note keeping detail may impede abstracting
specifics of antibiotic use (dose, duration, etc.).
• Antibiotic stewardship is an issue in several of the EN-BIRTH study
participating hospitals. Shockingly few inpatients (10.6%) had a
blood culture done, and even fewer had a lumbar puncture (0.3%)
despite a documented clinically-defined infection diagnosis. Import-
antly, in Nepal, there was a much higher rate of blood cultures in
comparison to the other sites (81.7%). Few neonates received rec-
ommended antibiotics for the minimum duration of time. Both
these practices are likely to contribute to overtreatment and/or in-
appropriate use of antibiotics, and may fuel AMR rates.Key findings (Continued)
What next and research gaps?
• Exit interview surveys of women’s report are not accurate for
measuring coverage of antibiotics for neonatal infections, for
denominator and especially for numerator regarding specific
antibiotic names. This is consistent with previous research regarding
antibiotics for childhood pneumonia, where survey report was
inaccurate regarding both numerator and denominator. However,
women’s report of admission to a neonatal ward holds promise for
use in surveys and requires further research. This indicator could be
analogous to other “contact” point indicators such as institutional
birth, with scope to link with data on quality of care.
• The gap for laboratory investigations of clinically-defined neonatal
infections is a major challenge hence wider use of blood cultures
and laboratory capacity strengthening are crucial and success in one
of the five EN-BIRTH study hospitals shows this is possible in LMICs.
Neonatal sepsis diagnostic innovation is an important investment
gap especially given increasing AMR.
• Implementation research is required to assess feasibility and utility of
a ward register for inpatient small and sick newborn care focusing
on major neonatal conditions including infection diagnoses and
antimicrobial use, as well as the transition into electronic systems,
with a minimal core dataset.Background
Infections, including sepsis, pneumonia and meningitis,
account for one-third of all newborn deaths globally [1, 2].
More than half a million newborns die every year due to
infections, and the majority of these deaths occur in low-
and middle-income countries (LMICs), mainly in south
Asia and sub-Saharan Africa [3–5]. Without significantly
accelerating the annual rate of reduction, global efforts
will not be enough to achieve the ambitious Sustainable
Development Goal (SDG) target of reducing the neonatal
mortality rate to ≤ 12 per 1000 live births by 2030 [6–8].
Mortality is only the tip of this iceberg of disease burden,
as there are an estimated 7 million episodes of possible
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around 3.5 million are in south Asia and 2.6 million in
sub-Saharan Africa [9]. In total estimated 30 million small
and sick newborns require hospital admission, many of
whom are given antibiotics [10]. The rate of hospital-
acquired infections and antimicrobial resistant (AMR) in-
fections among newborns may further increase due to the
trend towards rapid increase in the proportion of births in
health facilities in LMICs, and high use of antibiotics often
without blood cultures or other diagnostics [11, 12].
Early appropriate management of neonatal infections
is critical for newborn survival. The World Health
Organization (WHO) recommends inpatient management
of infections among newborns with injectable antibiotics
[13]. Early administration of appropriate injectable
antibiotics with supportive care could avert hundreds of
thousands of deaths a year [14–16]. However, substantial
gaps exist between such recommendations and
implementation [17–19], and there is a dearth of studies
to inform measuring the coverage and quality of inpatient
management of infections, particularly in LMIC contexts.
Accurate data are crucial to track progress towards the
SDGs and the global vision to end all preventable
maternal and newborn mortality as well as stillbirths.
The Every Newborn Action Plan (ENAP) identified a set
of core and additional indicators to be measured globally
to monitor and track the progress of newborn health. A
multi-partner ENAP measurement improvement road-
map was developed to validate these indicators [20]. The
proportion of hospitalized neonates with clinically diag-
nosed infections who received injectable antibiotics [de-
noted in this manuscript as “coverage” of injectable
antibiotics in this target group] was included in the
roadmap as one of the core coverage indicators for glo-
bal monitoring after validation and feasibility testing.
The first step towards robust measurement of
coverage is applying standardised case definitions. An
important challenge is that neonatal infections are
primarily defined based on symptoms and signs, which
are often poorly codified, and sick neonates commonly
have multi-organ dysfunction [21]. For outpatient and
primary care settings WHO recommends a simplified
clinical algorithm [22], designed to be highly sensitive
and non-specific and hence the majority of cases likely
have no bacterial infection [4]. For inpatient care of neo-
natal infections, with more experienced clinicians, a syn-
dromic classification is used to try to separate sepsis,
pneumonia and meningitis (Fig. 1a) and this inpatient
context is the focus of the Every Newborn - Birth Indica-
tors Research Tracking in Hospitals (EN-BIRTH) study.
Blood culture remains the gold standard diagnosis, even
though this may be negative in more than half of cases
where skilled clinicians are confident of the diagnosis
(Fig. 1b) [9, 23]. Importantly, meningitis cannot bedistinguished from sepsis by clinical examination alone
in a neonate and relies on consistent use of lumbar
puncture. Laboratory diagnosis require at least a basic
microbiological culture capacity, but to get more accur-
ate measures for fastidious organisms such as Group B
Streptococcus, requires specific approaches for culturing
and more capacity [23].
The next step is that coverage data should be routinely
available at scale in either surveys or routine health
management information systems (HMIS). Many LMICs
still depend on population-based surveys such as The
Demographic and Health Surveys (DHS) Program and
Multiple Indicator Cluster Surveys (MICS) to report
coverage for health care use including for management
of childhood illnesses [24, 25]. One important issue is
the challenge of measuring denominators of clinical
need, especially in surveys. Previous research found chal-
lenges with accuracy of recall of denominators regarding
childhood infections, notably pneumonia [26]. Another
study found that survey-reported pneumonia had low
validity with low true positive cases with high levels of
false positives [27]. Studies have shown that more ex-
tended recall periods (classically 2–5 years in for MICS/
DHS) for caregiver-reported symptoms of childhood ill-
nesses especially for newborns, are prone to recall bias
and recall error [28, 29].
Despite increasing opportunities to improve
measurement in routine facility-based information sys-
tems, there has been little research on coverage validity
for newborn care. This is an important opportunity,
given that ~ 80% of the world’s births are now in facil-
ities [30] coverage for newborn care has also increased,
and many LMICs are adopting different digital innova-
tions and transforming paper-based reporting system to
digital platforms [31, 32]. However, the majority of the
record-keeping system and registers are still paper-
based, including for inpatient care. Moreover, collating
other relevant data from various care areas make the
documentation process more strenuous. In settings with
limited resources, inpatient records are mostly based on
case notes/case recording forms, that are not standar-
dised and may have variable data quality [33].
As yet, no published studies have assessed the validity of
survey report for clinically-defined neonatal infections, to
inform the use of surveys to collect coverage data on this
important aspect of universal health coverage, or explored
feasibility for capture in facility data systems.
Objectives
This paper is part of a supplement based on the EN-
BIRTH multi-country validation study, ‘Informing meas-
urement of coverage and quality of maternal and new-
born care’, and focuses on injectable antibiotic treatment
of clinically-defined neonatal infections (sepsis,
a
b
Fig. 1 Case definitions and diagnosis for neonatal infections. a Approaches to diagnosis of neonatal infection, from simplest clinical algorithm, to
infection syndromes through to gold standard with laboratory confirmation (Figure adapted from Seale et al, Lancet Infect Dis, 2014) [9]. b Case
ascertainment for neonatal invasive bacterial disease showing the cascade affecting gold standard detection (Figure adapted from Lawn et al,
Clinical Infectious Diseases, 2017) [23]
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ing the following objectives:
1. VALIDATION of women’s report through exit
survey to determine the accuracy/validity for
a. Denominator options: The following
denominator options were assessed-Option d1- Reported the baby was admitted
to newborn ward
Option d2- Reported the baby was admitted
and had any infection
Option d3- Reported the baby was admitted and
had any one of the clinically-defined infection
syndromes. i.e. sepsis, pneumonia, meningitis
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options were assessed-
Option n1- Reported the baby received any
injection/antibiotic
Option n2- Reported the baby received any
injection/antibiotic and reported the antibiotic
name2. QUALITY GAP ANALYSES for injectable
antibiotic use to assess the gaps in coverage, quality
and measurement from case note verification.
3. BARRIERS AND ENABLERS to understand the
barriers and enablers of documentation practices
from qualitative interviews.
Methods
The EN-BIRTH study was conducted in five referral
hospitals: Maternal and Child Health Training Institute
(MCHTI), Azimpur and Kushtia General Hospital in
Bangladesh (BD), Pokhara Academy Health Sciences in
Nepal (NP), and Muhimbili National Hospital and Temeke
District Hospital in Tanzania (TZ) (Additional file 1). These
hospitals were selected since all the maternal, and neonatal
interventions of interest were available. The participants
were consenting women (primary caregivers of newborns)
whose baby was admitted to the hospital inpatient depart-
ment (newborn and paediatric wards) and treated for neo-
natal infection. Detailed information regarding the research
protocol, methods, and analysis were published separately
[34, 35]. In this study, we compared clinically-defined neo-
natal infection verified through abstraction of data from in-
patient case notes (gold standard) with women’s report
collected through exit surveys (Fig. 2).
Data collection
We adopted both quantitative and qualitative methods
of data collection to address the study objectives. Data
collection took place between July 2017 and July 2018.
Details regarding the clinical management practices
were verified by abstracting data from hospital inpatient
case notes/case recording forms with a structured
checklist. Exit surveys were conducted with a structured
questionnaire to capture women’s report before
discharge. These quantitative data collection tools were
developed by team members from Bangladesh, Nepal,
Tanzania and UK based on the global guidelines and
validated tools [13, 36, 37]. The data collection tools
were adapted to reflect country settings and contexts
(health systems, language, culture, etc.) through
formative research. Trained data collectors collected
data using a custom-built android tablet-based electronic
data capture system specially designed for the EN-
BIRTH study. Separate researchers were assigned to ver-
ify the hospital inpatient case notes, in addition to those
assigned to conduct the exit surveys. Around 5% of thecase note verifications were re-checked by field supervi-
sors to monitor the reliability of data collection.
In-depth interviews and focus group discussions were
conducted by trained qualitative researcher to explore
potential barriers and enablers related to documentation
practices. Qualitative data collection tools were informed
by the Performance of Routine Information System
Management (PRISM) conceptual framework [38, 39]. We
obtained ethical approval from the institutional review
boards in all operating counties in addition to the London
School of Hygiene & Tropical Medicine (Additional file 2).
Eligibility criteria
All babies aged ≤28 days at admission, weighing > 1500
grammes (g) at admission or discharge, or gestational
age > 32 weeks, receiving inpatient management for
clinically-defined infections, i.e. sepsis, pneumonia, menin-
gitis were included for analysis in this paper. Babies with
an obvious major congenital abnormality, neonatal en-
cephalopathy (“severe asphyxia”) were excluded at recruit-
ment. All inclusion and exclusion criteria were based on
the data abstracted from hospital inpatient records.
Data analyses
Results are reported in accordance with STROBE
Statement checklists for observational studies
(Additional file 3). We reported the background
characteristics of newborns treated for clinically-defined
infections and the women (primary caregivers) who were
successfully interviewed. Socioeconomic asset scores were
generated using the standard principal component ana-
lysis procedure. The EN-BIRTH larger dataset was used
for the assignment of wealth quintile to the neonatal infec-
tion cases [34, 35].
We reported the antibiotic coverage among newborns
treated for clinically-defined infections for the following
scenarios based on the hospital inpatient case note verifi-
cation: any injectable antibiotic, any WHO recommended
injectable antibiotic, any recommended injectable anti-
biotic for 2 days, any recommended injectable antibiotic
for 7 days. Survey-reported antibiotic coverage was re-
ported for two questions: general- reported any injection
or antibiotic was given, and specific- reported the name of
a specific antibiotic. We used descriptive statistics to re-
port all point prevalence estimates with 95% confidence
intervals. We reported all estimates separately for each of
the five facilities, as well as pooled estimates through ran-
dom effect models with heterogeneity statistics (I2 and τ2).
We conducted individual level validation analyses of
women’s report for the different denominator and
numerator options. Hospital inpatient case note
verification was considered as gold standard, and
women’s report during the exit survey was regarded as
the ‘Test’ during this analysis (Fig. 2). The denominator
Fig. 2 EN-BIRTH study antibiotic coverage validation design comparing case note verification with exit interview survey [34]
Rahman et al. BMC Pregnancy and Childbirth 2020, 21(Suppl 1):229 Page 6 of 17options included whether the women could correctly
report if the baby was admitted in the hospital (option
d1), if the baby was admitted and had any infection
(option d2), and if the baby was admitted and had any
clinically-defined infection (option d3). The numerator
options included whether the women could correctly re-
port if their baby received an injection or antibiotics (op-
tion n1) and whether the women could specifically
report the name of an antibiotic (option n2).
For validity measures, sensitivity and specificity were
reported with 95% confidence interval for each of the
selected hospital separately. Exit survey reported “Don’t
know” category was considered as “No” during this
analysis. Also, we reported the percent-agreement be-
tween the case note verification and the exit survey. Sen-
sitivity and specificity analyses were only performed if
the column total counts in two-way tables exceeded 10.
For denominator validation, we did not report the sensi-
tivity, specificity and percent agreement as we only had
newborns treated for clinically-defined infections, i.e. no
“true negatives.”
Structured Query Language (SQL) server was used to
store and manage data. We used Stata (version 14) for
conducting all quantitative analysis. NVivo 12 software
was used to manage qualitative data during analysis.
Results
A total of 1015 cases were selected based on the inclusion
and exclusion criteria (from 1523 recruited), among which
409 newborns were from Bangladesh, 344 were from
Nepal, and 262 were from Tanzania. Among 1015 eligible
cases, 910 women (primary caregivers of the newborns)
were successfully interviewed, 57 women were lost tofollow up, and 48 women did not consent to participate in
the study. Figure 3 summarises the selection process,
regarding the distribution of different inclusion and
exclusion criteria among the overall sample.
Background characteristics, clinical history and results
of physical examination of the newborns on admission
as recorded in the hospital inpatient case notes are
shown in Table 1. Among all newborns treated for
clinically-defined infections, 78.3% in Azimpur BD,
76.9% in Kushtia BD and 75.5% in Muhimbili TZ, and
around 99% in Pokhara NP and Temeke TZ were re-
corded as sepsis cases. Around 20% of the babies in
Azimpur BD and Kushtia BD and less than 1% of the
newborns in Pokhara NP and Temeke TZ were recorded
as pneumonia cases. The majority of the newborns were
less than 7 days of age, except in Muhimbili TZ (24.5%),
where the majority were aged between 7 and 13 days
(46.9%). 36.3% of the newborns in Kushtia BD and 12.3%
in Muhimbili TZ had a history of low birthweight (<
2500 g). Weight on admission was not recorded for less
than 10% cases in Azimpur BD and Kushtia BD, 22.4%
in Muhimbili TZ and more than 70% in Pokhara NP
and Temeke TZ.
Additional file 4 presents the characteristics of the
mothers of the newborns who participated in the exit
survey—the majority of these mothers were aged
between 20 and 29 years. 28.8% women completed
secondary education in Kushtia BD and 61.0% in
Pokhara NP.
Objective 1: Denominator and numerator validation
Table 2 presents the denominator validation results of
women’s reports during the exit survey, which were
Fig. 3 EN-BIRTH study flow diagram for newborns treated with severe infections (n = 1015)
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verification. Among the 910 women surveyed, 98.8%
could report their baby was admitted in the hospital,
which was consistent across all facilities. 47.1% of
women could report their baby was admitted in the
hospital and had any infection, which varied across
different hospitals, ranging from 17.1% (6.5–33.6%) in
Muhimbili TZ to 75.4% (70.1–80.1%) in Kushtia BD.
Only 30.4% (10.0–55.91%) of women could report if
their baby was admitted in the hospital and had a
clinically-defined infection, which also varied substan-
tially across different hospitals, ranging from 11.4%
(3.2–26.7%) in Muhimbili TZ to 70.4% (64.9–75.5%)
in Kushtia BD.
Overall, 74.7% (55.3–90.1%) of women could report
their baby received any antibiotics/injections during
their hospital stay: more than 80% in Azimpur BD,
Temeke TZ and Muhimbili TZ; whereas only 58.1% in
Kushtia BD and 46.8% in Pokhara NP (Fig. 4). Around
one-third of women in Kushtia BD and one-fourth of
women in Pokhara NP mentioned that they did notknow or remember whether their baby received any
antibiotic/injection. The sensitivity of women’s report
whether their babies received any antibiotic/injection
was 75.9% (Table 3, Additional files 5 and 6).
12.3% (3.5–25.1%) of women could report the
specific name of an antibiotic. 35.2% of women in
Kushtia BD and 25.0% of women in Pokhara NP
mentioned that they did not know or remember the
specific name of the antibiotic. The sensitivity of
reporting the name of the specific antibiotic was only
12.7%.
Objective 2: Gaps in coverage, quality and measurements
Table 4 describes the diagnostic practices received by
newborns treated for infection, according to the hospital
inpatient case note verification. Documentation of blood
culture being performed was available only among 10.6%
of newborns who were treated for clinically-defined in-
fections. The rate was less than 5% in Bangladesh and
Tanzania and 81.7% in Nepal. Less than 1% of newborns
had any documented evidence of a lumbar puncture
Table 1 Characteristics of newborns in inpatient wards, case note verification, EN-BIRTH study (n = 1015 children)
Bangladesh Nepal Tanzania
Azimpur Tertiary Kushtia District Pokhara Regional Temeke Regional Muhimbili National
N = 106 N = 303 N = 344 N = 213 N = 49
n (%) n (%) n (%) n (%) n (%)
Age
≤ 6 days 67 (63.2) 151 (49.8) 259 (75.3) 153 (71.8) 12 (24.5)
7–13 days 17 (16) 60 (19.8) 42 (12.2) 34 (16) 23 (46.9)
14–20 days 13 (12.3) 42 (13.9) 19 (5.5) 13 (6.1) 9 (18.4)
21–28 days 9 (8.5) 50 (16.5) 24 (7) 13 (6.1) 5 (10.2)
Sex
Male/Boy 59 (55.7) 183 (60.4) 225 (65.4) 127 (59.6) 30 (61.2)
Birth weight
1500–2000 g 7 (6.6) 38 (12.5) 15 (4.4) 14 (6.6) 4 (8.2)
2000–2500 g 20 (18.9) 72 (23.8) 54 (15.7) 30 (14.1) 2 (4.1)
2500+ g 65 (61.3) 165 (54.5) 263 (76.5) 165 (77.5) 40 (81.6)
Others 14 (13.2) 28 (9.2) 12 (3.5) 4 (1.9) 3 (6.1)
Weight at admission
1500–2000 g 5 (4.7) 41 (13.5) 3 (0.9) 3 (1.4) 0 (0)
2000–2500 g 26 (24.5) 81 (26.7) 12 (3.5) 7 (3.3) 5 (10.2)
2500+ g 67 (63.2) 157 (51.8) 80 (23.3) 29 (13.6) 33 (67.3)
Others 8 (7.5) 24 (7.9) 249 (72.4) 174 (81.7) 11 (22.4)
History
Not Feeding Well 43 (40.6) 37 (12.2) 42 (12.2) 77 (36.2) 18 (36.7)
Lethargy/reduced consciousness 6 (5.7) 2 (0.7) 16 (4.7) 14 (6.6) 9 (18.4)
Convulsion 3 (2.8) 8 (2.6) 12 (3.5) 21 (9.9) 7 (14.3)
Fever 44 (41.5) 25 (8.3) 211 (61.3) 127 (59.6) 20 (40.8)
Respiratory distress or fast breathing 36 (34) 35 (11.6) 45 (13.1) 20 (9.4) 7 (14.3)
Physical examination
Fever (> 38 degree) 28 (26.4) 298 (98.3) 172 (50) 81 (38) 10 (20.4)
Hypothermia (< 35 degree) 3 (2.8) 0 (0) 0 (0) 1 (0.5) 0 (0)
Respiratory Rate (> 60/min) 40 (37.7) 23 (7.6) 135 (39.2) 29 (13.6) 9 (18.4)
Bulging Fontanels 0 (0) 0 (0) 0 (0) 2 (0.9) 2 (4.1)
Umbilical redness and draining pus 8 (7.5) 0 (0) 3 (0.9) 5 (2.3) 3 (6.1)
Skin Pustules 2 (1.9) 2 (0.7) 11 (3.2) 3 (1.4) 3 (6.1)
Diagnosis at admission
Sepsis 83 (78.3) 233 (76.9) 341 (99.1) 211 (99.1) 37 (75.5)
Pneumonia 23 (21.7) 70 (23.1) 1 (0.3) 1 (0.5) 8 (16.3)
Meningitis 0 (0) 0 (0) 2 (0.6) 1 (0.5) 4 (8.2)
Baby’s condition at discharge
Alive 106 (100) 272 (89.8) 342 (99.4) 196 (92) 45 (91.8)
Death 0 (0) 1 (0.3) 1 (0.3) 5 (2.3) 4 (8.2)
Not Recorded 0 (0) 30 (9.9) 1 (0.3) 12 (5.6) 0 (0)
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admission diagnosis of meningitis, a lumbar puncture
was performed in only three cases (data not shown).Only one-fifth of all newborns treated for infection had
any documented evidence of high white blood cell
(WBC) count.
Table 2 Denominator validation results for coverage of injectable antibiotics, women’s exit interview survey, EN-BIRTH study (n = 901)
Country Hospital Survey Reported Coverage Don’t Know Response
N % (95% CI) %
Baby admitted in hospital Bangladesh Azimpur Tertiary 103 99 (93, 99.8) 0
Kushtia District 301 99 (96.9, 99.0) 0
Nepal Pokhara Regional 316 97.2 (94.6, 98.5) 0.32
Tanzania Temeke Regional 146 99.3 (95.2, 99.9) 0.68
Muhimbili National 35 100 0
All sites pooled Random effects estimate 901 98.8 (97.8, 99.5) 0.2
Baby admitted in hospital and
had any infection
Bangladesh Azimpur Tertiary 103 41.7 (32.1, 51.8) 0
Kushtia District 301 75.4 (70.1, 80.1) 7.64
Nepal Pokhara Regional 316 58.8 (53.2, 64.3) 2.53
Tanzania Temeke Regional 146 38.3 (30.4, 46.7) 4.11
Muhimbili National 35 17.1 (6.5, 33.6) 8.57
All sites pooled Random effects estimate 901 47.1 (30.1, 64.5) 3.45
Baby admitted in hospital and
had a presumed severe infection
Bangladesh Azimpur Tertiary 103 30.1 (21.5, 39.9) 2.91
Kushtia District 301 70.4 (64.9, 75.5) 11.3
Nepal Pokhara Regional 316 17.4 (13.3, 22.0) 6.33
Tanzania Temeke Regional 146 26.7 (19.7, 34.6) 4.79
Muhimbili National 35 11.4 (3.2, 26.7) 8.57
All sites pooled Random effects estimate 901 30.4 (10.0, 55.9) 6.48
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in various hospitals according to the case note
verification. The choice of antibiotic differed across
different hospitals despite the high coverage of
antibiotics across all sites. In all hospitals except Kushtia
BD, ampicillin (63.4–90.6% across facilities) and
gentamicin (69.4–92.5% across facilities) were the most
commonly used antibiotics. In Kushtia BD, gentamicin
(71.6% with CI 66.1–76.6%), ceftazidime (69.3% with CI
63.7–74.4%) and meropenem (28.1% with CI 23.1–
33.5%) were the most frequently used. In addition to
ampicillin and gentamicin, ampicillin-cloxacillin (29.6%
with CI 23.5–36.1%) was one of the most commonly
used in antibiotics in Temeke TZ.
Figure 5 shows the gap analysis for coverage of
antibiotic use among newborns treated for clinically-
defined infections through the hospital inpatient case
note verification (first six stacked bars from left) and
gaps in measurements through women’s report at exit
survey (the last two stacked bars). Among all the
newborns treated for infection, 96.7% had docu-
mented evidence of receiving any WHO recom-
mended injectable antibiotic for any duration, 73.3%
receiving any recommended injectable for at least 2
days and 14.5% receiving any recommended injectable
for at least 7 days.Objective 3: Barriers and enablers to documentation
practices in hospital inpatient case notes
We identified the following key themes regarding
documentation practices in hospital inpatient case notes:
Enabler – awareness regarding the importance case note
records: The health workers, i.e. doctors and nurses
responsible for inpatient management of sick newborns,
were aware of the importance of documentation in the
inpatient case notes and medical record keeping. They
acknowledged its importance for reviewing the patient’s
condition and taking clinical decisions, communicating
and coordinating within the clinical team (doctors’
instructions to the junior doctors and nurses, nurses’
action in response to the guidelines, etc.), and
preparing discharge certificates.
Enabler – source of information for service reports: The
health services providers, especially the nurses,
regularly used case notes as a source of information for
preparing different services reports (daily/monthly
reports) and disease-specific registries.
Barrier – case note design and lack of
standardization: The case notes had a basic
structure outlining some key components (particulars
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investigations, drugs given, etc.). The design of the
case notes varied substantially across countries, and
it did not prioritize any standardized documentation
of key clinical care elements. Consequently, the
documentation practice was dependent on the
preference and performance of the clinical service
providers, leading to unstandardized documentation








1 Neonatal Infection - Antibiotic/Injection - Survey reported
Observer coverage % 99.0 (93.4, 99.9) 96.3 (93.4, 97.9) 92.6 (
Survey reported coverage % 82.5 (73.9, 88.7) 58.1 (52.5, 63.6) 46.8 (
"Don’t know” responses % 9.7 (5.3, 17.2) 35.2 (30.0, 40.8) 25.0 (
Sensitivity % (95% CI) † † 57.8 (51.8, 63.6) 47.8 (
Specificity % (95% CI) ‡ ‡ 54.5 (23.4, 83.3) 62.5 (
Percent agreement (TP+TN)/n % 84.2 (75.6, 90.7) 57.7 (51.8, 63.4) 48.9 (
2 Neonatal Infection - Antibiotic name - Survey reported
Observer coverage % 99.0 (93.4, 99.9) 96.3 (93.4, 97.9) 92.6 (
Survey reported coverage % 4.9 (2.0, 11.2) 25.2 (20.6, 30.5) 3.2 (
"Don’t know” responses % 9.7 (5.3, 17.2) 35.2 (30.0, 40.8) 25.0 (
Sensitivity % (95% CI) † † 26.2 (21.2, 31.8) 3.5 (
Specificity % (95% CI) ‡ ‡ 90.9 (58.7, 99.8) 100.0 (
Percent agreement (TP+TN)/n % 5.9 (2.2, 12.5) 28.7 (23.6, 34.2) 10.9 (
Validity statistics suppressed where < 10 count in either column of two-by-two tablproviders felt the need for specific training related to
documentation of inpatient care.
Barrier – lack of coordination and duplication with
other registers: In addition to case notes, nurses had to
maintain other administrative registers such as drugs log,
logistic requisition, etc. which also include various
patient-related information (which are already avail-
able in the case notes) leading to duplication ofnjectable antibiotics coverage, EN-BIRTH study (n = 901)
Tanzania All sites pooled
(Random Effects)







89.3, 95.0) 95.6 (91.8, 97.7) 100.0 (92.5, 100.0) 96.7 (94.0, 98.6)
41.4, 52.4) 91.1 (85.2, 94.8) 88.6 (72.9, 95.7) 74.7 (55.3, 90.1)
20.5, 30.1) 6.8 (3.7, 12.3) 11.4 (4.3, 27.1) 16.9 (7.4, 29.2)
41.9, 53.7) † † † † 75.9 (55.6, 91.6)
40.6, 81.2) ‡ ‡ ‡ ‡ ‡ ‡
43.2, 54.6) 90.8 (84.9, 95.0) 88.6 (73.3, 96.8) 75.3 (56.4, 90.2)
89.3, 95.0) 95.6 (91.8, 97.7) 100.0 (92.5, 100.0) 96.7 (94.0, 98.6)
1.7, 5.8) 21.2 (15.3, 28.7) 14.3 (6.0, 30.4) 12.3 (3.5, 25.1)
20.5, 30.1) 6.8 (3.7, 12.3) 11.4 (4.3, 27.1) 16.9 (7.4, 29.2)
1.7, 6.3) † † † † 12.7 (3.7, 25.6)
85.8, 100.0) ‡ ‡ ‡ ‡ ‡ ‡
7.6, 14.8) 23.9 (17.2, 31.8) 14.3 (4.8, 30.3) 16.1 (8.0, 26.2)
e
Table 4 Laboratory investigations and diagnostics, case note verification, EN-BIRTH study (n = 1015)











N = 106 N = 303 N = 344 N = 213 N = 49 N = 1015
n (%) n (%) n (%) n (%) n (%) %
Confirmatory Lab Diagnosis
Blood Culture Done 2 (1.9) 2 (0.7) 281 (81.7) 1 (0.5) 2 (4.1) 10.6
Blood Culture Positive 0 (0) 0 (0) 206 (59.9) 0 (0) 1 (2) 5
LP Done 0 (0) 0 (0) 5 (1.5) 0 (0) 2 (4.1) 0.3
LP CSF Appearance Positive 0 (0) 0 (0) 1 (0.3) 0 (0) 0 (0) 0
LP CSF Culture Positive 0 (0) 0 (0) 1 (0.3) 0 (0) 0 (0) 0
LP CSF Clinical Appearance Positive
or Culture Positive
0 (0) 0 (0) 2 (0.58) 0 (0) 1 (2.0) 0.1
Either Blood Culture Positive OR
CSF Positive
0 (0) 0 (0) 207 (60.2) 0 (0) 2 (4.1) 5.5
Other Supportive Lab Diagnosis
CBC Done 5 (4.7) 9 (3) 309 (89.8) 1 (0.5) 32 (65.3) 25.7
WBC Count High 1 (0.9) 0 (0) 192 (55.8) 1 (0.5) 15 (30.6) 10.3
Either Blood Culture Positive or CSF
Positive or WBC high
1 (0.9) 0 (0) 277 (80.5) 1 (0.5) 16 (32.7) 14.2
LP lumbar puncture, CSF Cerebrospinal fluid, CBC Complete blood count, WBC White blood cell
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Bangladesh said:
“There are too many registers to fill up. Information
related to neonatal infection is recorded into the
admission book, patient case file, and monthly
summary sheet. To do so in a proper way, it needs a
considerable amount of time.”
- Health worker, BD
Barrier – clinical workload and documentation
responsibilities: In addition to the clinical
duties, the doctors and nurses were separately
responsible for filling-in different sections of
the case notes. The majority of the health
workers felt that their clinical workload was
overwhelming and affected the quality of case
note documentation.
Discussion
This analysis, as part of EN-BIRTH study, is the first to
validate potential coverage indicator measurement for
antibiotic treatment of neonatal infections in hospita-
lised patients. Based on more than 1000 cases in five
hospitals in Bangladesh, Nepal and Tanzania, we vali-
dated women’s report during exit survey against infor-
mation abstracted from hospital inpatient case notes
[35]. Given our findings of large measurement gaps of
women’s report, we do not recommend incorporatingthis indicator in widely deployed population-based sur-
veys like DHS and MICS [24, 25].
Maternal report of newborn admission in the
inpatient ward had high sensitivity, but specific
diagnosis or classifications were poorly reported, with
high “Don’t knows”. Infections are a subset of the total
neonatal admissions, varying by context and especially
by level of facility, with reports between 6 and 68% of
all neonatal admissions [40–49]. Using a contact
indicator option (admission to a neonatal unit) in
household surveys may be useful as marker of care for
small and sick newborns, in a similar way that
“contact” point indicators such as institutional birth or
antenatal care coverage are used. We note that only
women whose babies had been admitted were
surveyed, so more research is required to also ask
those whose baby was not admitted. Importantly this
“contact” point indicator would also need to be linked
to more detailed diagnosis and treatment information,
from inpatient datasets for example.
More detailed questions to try to identify
denominators of clinical diagnosis were asked in two
ways (any infection, or specific infection syndrome), and
both of these performed poorly in survey report. Around
half of the women could correctly report whether their
baby had any infection, and only around one-third could
report any specific infection syndromes (sepsis, meningi-
tis or pneumonia). Moreover, there were wide variations
among different hospitals regarding the accuracy of
women’s report on the second (if baby admitted in
Table 5 Injectable antibiotic use and coverage, case note verification, EN-BIRTH study (n = 1015)
Name of antibiotic Bangladesh Nepal Tanzania
Azimpur Tertiary Kushtia District Pokhara Regional Temeke Regional Muhimbili National
N = 106 N = 303 N = 344 N = 213 N = 49
n (% - CI) n (% - CI) n (% - CI) n (% - CI) n (% - CI)
Amikacin 4 (3.8 – (1.0–9.4)) 44 (14.5– (10.7–19.0)) 55 (16 – (12.2–20.3)) 0 (0) 0 (0)
Ampicillin 96 (90.6 – (83.3–95.3)) 0 (0) 257 (74.7 – (69.7–79.2)) 135 (63.4 – (56.5–69.8)) 33 (67.3– (52.4–80.0))
Ampicillin-Cloxacillin 0 (0) 0 (0) 0 (0) 63 (29.6 – (23.5–36.1)) 0 (0)
Amoxycillin-Cloxacillin 0 (0) 0 (0) 0 (0) 0 (0) 1 (2 – (0.0–10.8))
Azithromycin 0 (0) 1 (0.3 – (0.0–1.8)) 0 (0) 0 (0) 0 (0)
Aztreonam 0 (0) 0 (0) 1 (0.3 – (0.0–1.6)) 0 (0) 0 (0)
Azoxystrobin (fungicide) 0 (0) 4 (1.3 – (0.3–3.3)) 0 (0) 0 (0) 0 (0)
Cefaclor 0 (0) 1 (0.3 – (0.0–1.8)) 0 (0) 0 (0) 0 (0)
Cefdinir-Flucloxacillin 0 (0) 0 (0) 1 (0.3 – (0.0–1.6)) 0 (0) 0 (0)
Cefixime 0 (0) 0 (0) 23 (6.7 – (4.2–9.8)) 0 (0) 0 (0)
Cephalexin 0 (0) 1 (0.3 – (0.0–1.8)) 0 (0) 0 (0) 0 (0)
Cefotaxime 0 (0) 2 (0.7 – (0.0–2.3)) 38 (11 – (7.9–14.8)) 1 (0.5 – (0.0–2.5)) 1 (2 – (0.0–10.8))
Ciprofloxacin 0 (0) 0 (0) 0 (0) 0 (0) 4 (8.2 – (2.2–19.6))
Cloxacillin 2 (1.9 – (0.2–6.6) 0 (0) 0 (0) 0 (0) 0 (0)
Cefepime 2 (1.9 - (0.2–6.6)) 1 (0.3 – (0.0–1.8)) 1 (0.3 – (0.0–1.6)) 0 (0) 0 (0)
Ceftriaxone 1 (0.9 – (0.02–5.1)) 19 (6.3 – (3.8–9.6)) 0 (0) 9 (4.2 – (1.9–7.8) 22 (44.9 – (30.6–59.7))
Flucloxacillin 1 (0.9 – (0.02–5.1)) 11 (3.6 – (1.8–6.4)) 14 (4.1 – (2.2–6.7)) 0 (0) 0 (0)
Gentamicin 98 (92.5 – (85.7–96.7) 217 (71.6 – (66.1–76.6)) 270 (78.5 – (73.7–82.7)) 197 (92.5 – (88.0–95.6) 34 (69.4 – (54.5–81.7))
Mexidin 0 (0) 1 (0.3 – (0.0–1.8)) 0 (0) 0 (0) 0 (0)
Metronidazole 2 (1.9 – (0.2–6.6)) 56 (18.5 – (14.2–23.3)) 5 (1.5 – (0.5–3.3)) 2 (0.9 – (0.1–3.3)) 5 (10.2 – (3.3–22.2))
Moxifloxacin 0 (0) 1 (0.3 – (0.0–1.8)) 0 (0) 0 (0) 0 (0)
Meropenem 0 (0) 85 (28.1 – (23.1–33.5)) 2 (0.6 - (0.0–2.0)) 0 (0) 2 (4.1 (0.5–13.9)
Ofloxacin 0 (0) 0 (0) 1 (0.3 – (0.0–1.6)) 0 (0) 0 (0)
Ceftazidime 5 (4.7 – (1.5–10.7)) 210 (69.3 – (63.7–74.4)) 4 (1.2 – (0.3–2.9) 0 (0) 0 (0)
Tobramycin 0 (0) 0 (0) 2 (0.6 - (0.0–2.0)) 0 (0) 0 (0)
Vancomycin 0 (0) 0 (0) 5 (1.5 – (0.5–3.3)) 0 (0) 0 (0)
Antibiotic - Unspecified 0 (0) 8 (2.6 – (1.1–5.1)) 0 (0) 0 (0) 0 (0)
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option (if baby admitted in hospital and had a presumed
severe infection (11.4–70.4%). These findings are con-
sistent with the previous studies which reported the
challenges of identifying clinical symptoms through
household surveys [26, 27, 50]. In our EN-BIRTH study,
the sensitivity of women’s report was assessed through
exit survey. In contrast, standard surveys like DHS and
MICS accept a recall period of 14 days for identifying
suspected cases suffering from acute respiratory infec-
tions. Since recall bias and recall error increase with lon-
ger recall periods, the accuracy of women’s report
collected through the last two denominator options in
household surveys may be further compromised [28, 29].
The numerators assessed involved questions regarding
the use of injectable antibiotics. For use of anyantibiotic, the sensitivity was 75.9%, with wide variation
between the five participating hospitals. In terms of
mothers’ knowledge regarding which antibiotic was
given, sensitivity was only 12.7%. This was reasonably
consistent across all hospitals. During hospital stay, a
sick newborn may require different kinds of injectable
drugs in addition to antibiotics [13]. Therefore, the
general option (any injection) may overestimate the true
coverage of injectable antibiotic for treating newborns
with infections. Moreover, antibiotics are often
prescribed using trade names (given by the
manufacturing companies), making it even more difficult
for women to report drug names correctly, and also
challenging to differentiate an antibiotic from other
drugs during analysis. Effective communication has been
underemphasised as part of respectful family-centred
Fig. 5 Gaps in coverage, quality and measurements in antibiotic use, EN-BIRTH study. (n = 1015 for case note verification and n = 910 exit
interview survey). *All sites pooled using random effects model
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might contribute to the limited sensitivity of women’s
report and high rates of “Don’t know” responses for this
option. Focusing only on hospitalised care might have
underestimated the coverage of injectable antibiotic [52].
However, the focus on this study was to assess the valid-
ity of hospital inpatient record-keeping and its implica-
tions on estimating the antibiotic coverage.
Hospital records are another potential data source for
tracking injectable antibiotic use, and could be linked to
a “contact” point indicator in surveys to assess effective
coverage [53]. We found gaps in the design of hospital
inpatient case notes and inconsistencies in
documentation practices by various health service
providers, and between the hospitals. Introduction of
clinical registers for inpatient management of sick
newborns may help address such gaps [54] and
contribute to better quality of care and patient outcomes
[55–57]. Implementation research is required to evaluate
the use of novel clinical registers. Shifting towards
electronic inpatient records and adopting new
technologies designed for resource-poor settings couldimprove the quality of documentation [58]. However,
managing an extensive electronic database can be chal-
lenging in any context, and requires adequate resourcing
[59, 60].
Antibiotic stewardship is an imperative in every country,
and neonates are especially vulnerable to antimicrobial-
resistant pathogens and more likely to die if infected [61].
There were gaps regarding the use of recommended anti-
biotics as included hospitals used around 30 types of in-
jectable antibiotics for treating newborns. Furthermore,
there are concerns regarding course completion, as less
than 10% of the newborns treated for clinically-defined in-
fections received the recommended antibiotics for 7 days
or more. Injudicious use of antibiotics may lead to anti-
biotic resistance which is a critical public health concern
in both resource-rich and resource-poor settings [62, 63].
Inappropriate provision or overuse of antibiotics also
brings an economic burden on the health system and fam-
ilies through out-of-pocket expenditure [64]. Knowledge
gaps among the doctors and patients’ expectations and
lack of understanding of the importance of completing an
antibiotic course by the family members may explain this
Rahman et al. BMC Pregnancy and Childbirth 2020, 21(Suppl 1):229 Page 14 of 17inappropriate and irrational use of antibiotics for treating
infections [65, 66].
In the EN-BIRTH study, verification of hospital in-
patient case notes revealed that almost all (97%) new-
borns admitted in the hospital for clinically-defined
infections received injectable antibiotics. However, very
few (< 2%) had laboratory-confirmed evidence of any in-
fection in Bangladesh and Tanzania. Importantly, in
Nepal, there was a much higher rate of blood culture.
Most likely this has happened as a result of the ongoing
quality improvement initiatives in Nepal. Diagnostic
tests are vital for managing newborns with infections
[13, 67]. It is also an important aspect of antibiotic stew-
ardship. Almost none of the newborns treated for
clinically-defined infections in Azimpur BD, Kushtia BD,
Temeke TZ and Muhimbili TZ had laboratory-
confirmed evidence of any infection. Other supportive
lab diagnoses such as a complete blood count (CBC) or
WBC count were also not performed in Azimpur BD,
Kushtia BD and Temeke TZ. This gap in diagnostic tests
may be the result of inadequate provision of laboratory
services in these resource-poor settings [68–70]. Ensur-
ing the basic laboratory services with quality and stand-
ardisation in referral hospitals should be prioritised for
improving the quality of care. It is important to explore
and understand the enablers of such practices in
Pokhara NP, and adapt learning for use in hospitals with
similar settings.
Strengths and limitations
Our study has strengths, notably the large sample size
and multi-country sites with standardised tools and
training and a custom-built android tablet-based applica-
tion that was designed specifically for this study [71].
Data abstraction from inpatient case notes was con-
ducted by trained study nurses, supervised by study-
physicians. Exit surveys with women were conducted by
trained data collectors. These measures helped to ensure
multi-site consistency and data quality through real-time
monitoring.
It is also important to acknowledge limitations.
Observations of the clinical practices in the selected
hospitals and especially timed observations of antibiotic
administered for neonatal infections were not feasible,
and hence we used inpatient case notes as the gold
standard to assess the validity of women’s report
through the exit survey. Whilst this is the most
commonly used gold standard in many validation
studies, It is widely recognised that case note
documentation has gaps, even in well-resourced settings
[72]. Validity assessment may be affected by the poten-
tial inaccuracy of case note documentation however, we
note that case notes are more likely to omit than have
false record of giving treatment, so if anything ourfindings are conservative, and the gap between “truth”
and reported coverage may be even higher. Within the
quality gap analyses gaps may be related to documenta-
tion as well as gaps in quality of care. The survey and
our analyses were limited to cases admitted for infection;
therefore, we could not compare the true negatives for
women’s report.
Conclusion
Survey report consistently underestimated the coverage
of injectable antibiotics for treating newborns with
infection, and had low sensitivity for both the numerator
and denominator, hence we recommend this indicator
not be added to population-based surveys. However, the
high sensitivity of a “contact” point indicator of admis-
sion to a neonatal unit, at least amongst those admitted,
holds promise for tracking coverage of small and sick
newborn care. More investment and research on hos-
pital inpatient records for newborns is crucial to enable
linked data on content and quality of care. We particu-
larly recommend improving the design of inpatient reg-
isters and case notes to address the identified gaps in
measurements of quality of care. Strengthening capaci-
ties to do blood cultures and lumbar punctures is im-
portant in the short term, and in the longer term novel
bedside diagnostics for bacterial and viral neonatal infec-
tions could be transformative and also to improve anti-
biotic stewardship and address AMR.
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